Document Detail


Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine.
MedLine Citation:
PMID:  18040799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumor necrosis factor-alpha (TNF-alpha) is widely known to be involved in physiological and pathophysiological processes of the brain where this proinflammatory cytokine is implicated with regulation of inflammatory and survival components. We report that TNF-alpha up-regulates exon-IV-bdnf mRNA and brain-derived neurotrophic factor (BDNF) protein in primary astrocytes. The BDNF protein was detectable both in cellular lysate and in the extracellular medium. Activation of NF-kappaB by TNF-alpha and inhibition of TNF-alpha-induced BDNF expression by Deltap65 (a dominant-negative mutant) and NEMO-binding domain peptide (an inhibitor of NF-kappaB) suggests that TNF-alpha induces BDNF expression through the activation of NF-kappaB. Similarly, TNF-alpha induced the activation of C/EBPbeta and the expression of BDNF was sensitive to overexpression of DeltaC/EBPbeta (a dominant-negative mutant) and ETO (an inhibitor of C/EBPbeta). Among three MAP kinases, TNF-alpha-induced BDNF up-regulation was sensitive only to inhibitors of ERK MAP kinase. However, the ERK MAP kinase pathway was coupled to activation of C/EBPbeta but not NF-kappaB. Taken together, this study identifies a novel property of TNF-alpha in inducing the expression of BDNF via NF-kappaB and C/EBPbeta in astrocytes that may be responsible for neurotrophic activity of the cytokine.
Authors:
Ramendra N Saha; Xiaojuan Liu; Kalipada Pahan
Related Documents :
10551799 - Constitutive and inducible in vivo protein-dna interactions at the tumor necrosis facto...
17763929 - Inner anti-inflammatory mechanisms of petroleum ether extract from melilotus suaveolens...
17276889 - Differential effects of ginsenosides on no and tnf-alpha production by lps-activated n9...
12204819 - Ap-1, nf-kappa-b, and erk activation thresholds for promotion of neoplastic transformat...
18239189 - Ikk alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in...
22087269 - Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis...
2467889 - Expression of ia antigen by ocular tissues of mice treated with interferon gamma.
20435039 - Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
16982859 - Cutting edge: il-1beta mediates the proangiogenic activity of osteopontin-activated hum...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-05-16
Journal Detail:
Title:  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology     Volume:  1     ISSN:  1557-1904     ISO Abbreviation:  J Neuroimmune Pharmacol     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2007-11-27     Completed Date:  2007-12-27     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  101256586     Medline TA:  J Neuroimmune Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  212-22     Citation Subset:  IM    
Affiliation:
Section of Neuroscience, Department of Oral Biology, University of Nebraska Medical Center, 40th and Holdrege, Lincoln, NE 68583-0740, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Astrocytes / metabolism*
Blotting, Western
Brain-Derived Neurotrophic Factor / metabolism*
Cells, Cultured
Cytokines / metabolism
Electrophoretic Mobility Shift Assay
Enzyme-Linked Immunosorbent Assay
Extracellular Signal-Regulated MAP Kinases / metabolism
Gene Expression
Immunohistochemistry
NF-kappa B / metabolism
Neuroimmunomodulation / physiology*
Rats
Reverse Transcriptase Polymerase Chain Reaction
Tumor Necrosis Factor-alpha / metabolism*
Up-Regulation
Grant Support
ID/Acronym/Agency:
NS39940/NS/NINDS NIH HHS; NS48923/NS/NINDS NIH HHS; R01 NS039940-05A1/NS/NINDS NIH HHS; R21 NS048923-01A2/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Brain-Derived Neurotrophic Factor; 0/Cytokines; 0/NF-kappa B; 0/Tumor Necrosis Factor-alpha; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhanced immune sensitivity to stress following chronic morphine exposure.
Next Document:  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.